PUBLIC PRESS RELEASE OCTOBER[removed]Pres s Releas e

First Page		Document Content
Date: 2012-06-19 05:55:21 Eli Lilly and Company Lung cancer Lipoplatin Pemetrexed Carboplatin Cisplatin Non-small-cell lung carcinoma Gemcitabine Oxaliplatin Chemistry Alkylating antineoplastic agents Ammine complexes		PUBLIC PRESS RELEASE OCTOBER[removed]Pres s Releas e Add to Reading List Source URL: regulon.org Download Document from Source Website File Size: 1,65 MB Share Document on Facebook

	TECHNOLOGY OFFER www.wtz-ost.at NOVEL OXALIPLATIN PRODRUG A set of novel platinum (IV) oxaliplatin derivatives that are tumour-targeted through albumin binding have been synthesized and tested by collaborating DocID: 1ra9w - View Document
	References [1] R. A. Adams, A. M. Meade, A. Madi, D. Fisher, E. Kay, S. Kenny, R. S. Kaplan, and T. S. Maughan. Toxicity associated with combination oxaliplatin plus fluoropyrimidine with or without cetuximab in the MRC DocID: 1qSc2 - View Document
	xeloda oral solution recipe average dosage of xeloda xeloda cancer medication detoxification before taking xeloda xeloda copay assistance. cancer colon for xeloda. xeloda sensitizer. xeloda cancer spread control DocID: 1pxKT - View Document
	DOI: cphcCharacterizing Pt-Derived Anticancer Drugs from First Principles: The Case of Oxaliplatin in Aqueous Solution Elizabeth C. Beret,[a] Rafael R. Pappalardo,[a] Dominik Marx,[b] and Enrique Snc DocID: 1oOJ2 - View Document
	FOLFOXIRI Irinotekan Oxaliplatin Calciumfolinat 5-Fluorouracil DocID: 1ey7d - View Document